Litcius/Paper detail

Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China

Yunyun Fei, Lidan Zhao, Lijun Wu, Xiaoxia Zuo, Rongli Li, Jiaomei Cheng, Hui Luo, Xue Wu, Li Sun, Jingjing Xu, Yingxuan Zhu, Yang Wang, Zhu Chen, Xiaomei Li, Xiaofei Wang, Xuan Zhang, Yunyun Fei, Lidan Zhao, Lijun Wu, Xiaoxia Zuo, Rongli Li, Jiaomei Cheng, Hui Luo, Xue Wu, Li Sun, Jingjing Xu, Yingxuan Zhu, Yang Wang, Zhu Chen, Xiaomei Li, Xiaofei Wang, Xuan Zhang

2024Annals of the Rheumatic Diseases10 citationsDOI

Topics & Concepts

MedicineHydroxychloroquineInternal medicineClinical endpointRandomized controlled trialSystemic lupus erythematosusDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesMultiple Sclerosis Research Studies
Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China | Litcius